apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Perinorm Vial Injection
  3. Perinorm Vial Injection Substitute

Perinorm Vial Injection Substitute

Substitutes safety advice
call Doctor

Verified Ingredients and Effects

Composition:

METOCLOPRAMIDE-5MG

Uses:

Nausea, vomiting, delayed gastric emptying

Medicinal Benefits:

Perinorm Vial Injection belongs to a group of medicines called anti-emetics and prokinetic agents used to prevent nausea and vomiting caused by chemotherapy, radiotherapy, migraine, and in post-operative conditions. Additionally, Perinorm Vial Injection is also used to treat delayed gastric emptying. Perinorm Vial Injection may be used to facilitate small bowel intubation and to facilitate gastric emptying and intestinal transit of barium in patients where delayed emptying interrupts radiological examination of the stomach and/or small intestine. Perinorm Vial Injection contains ‘metoclopramide’ that works by increasing the motility of the upper gastrointestinal tract; this allows faster transit of food and treats gastric emptying. It also works on the part of the brain that controls vomiting, thereby helps in preventing nausea and vomiting.

FAQs

Perinorm Vial Injection works by increasing the motility of the upper gastrointestinal tract; this allows faster transit of food and treats gastric emptying. It also works on the part of the brain that controls vomiting, thereby helps in preventing nausea and vomiting.

Perinorm Vial Injection may cause tardive dyskinesia (movement disorder) that is often irreversible. The risk increases with the duration of treatment and dosage. Perinorm Vial Injection therapy should be discontinued in patients who develop the symptoms of tardive dyskinesia. Consult your doctor immediately if you notice symptoms such as involuntary movements of the face, tongue, mouth, jaw, trunk and/or extremities.

Perinorm Vial Injection may be used to facilitate small bowel intubation (the process of passing a small, flexible plastic tube through the nose/mouth into the stomach/small intestine) in adults and pediatric patients in whom the tube does not pass the pylorus (the opening from the stomach into the duodenum) with conventional manoeuvres.

Treatment with Perinorm Vial Injection should be avoided for longer than 12 weeks except in rare cases where benefits outweigh the risks of developing tardive dyskinesia.

Perinorm Vial Injection may cause depression in people with or without a medical history of depression. Consult your doctor immediately if you have any suicidal thoughts, such as killing or harming yourself.

Perinorm Vial Injection may be used to facilitate gastric emptying and intestinal transit of barium in patients where delayed emptying interrupts radiological examination of the stomach and/or small intestine.